Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Small Molecule Inhibitors
100%
Urothelial Carcinoma
100%
Potential Treatments
100%
PIM Kinase
100%
Family Members
40%
Invasive Urothelial Carcinoma
40%
Signaling Pathway
20%
Multiple Myeloma
20%
Prostate
20%
Tumor Growth
20%
Disease Progression
20%
Biopsy Specimen
20%
Overexpression
20%
Surgical Resection
20%
Cancer Cells
20%
Cell Proliferation
20%
Ether
20%
Downstream Effectors
20%
Oncogene
20%
Expression Level
20%
Leukemia
20%
Molecular Targets
20%
Positive Regulator
20%
Kinase Inhibition
20%
Targets for Therapy
20%
Poor Prognosis
20%
Lymphoma
20%
Serine-threonine Kinase
20%
Effector Function
20%
Colony Formation Assay
20%
Multiple Cancers
20%
Head-and-neck Cancer
20%
Integration Site
20%
Moloney murine Leukemia Virus
20%
Phase Progression
20%
Inhibitor of Apoptosis Proteins
20%
Surgical Biopsy
20%
Patient Tumor
20%
Oral Bioavailability
20%
High-grade Urothelial Carcinoma
20%
PIM-1
20%
PIM3
20%
PIM2
20%
Viral Integration
20%
Resection Specimen
20%
Medicine and Dentistry
Kinase
100%
Transitional Cell Carcinoma
100%
Bladder Cancer Cell Line
40%
Biological Marker
20%
Neoplasm
20%
Aciclovir
20%
Tumor Progression
20%
Multiple Myeloma
20%
Cell Signaling Pathway
20%
Phosphotransferase
20%
Phosphotransferase Inhibitor
20%
Cell Proliferation
20%
Cell Cycle
20%
Cancer Cell
20%
Diethyl Ether
20%
Programmed Cell Death
20%
Bioavailability
20%
Leukemia
20%
Colony Formation
20%
Disease Exacerbation
20%
Biopsy Technique
20%
Cytochrome P450
20%
Proteus Syndrome
20%
Proto Oncogene
20%
S Phase
20%
Head and Neck Cancer
20%
Xenograft
20%
Protein Serine Threonine Kinase
20%
Pharmacodynamics
20%
Surgery
20%
Biochemistry, Genetics and Molecular Biology
Small Molecule
100%
Cancer Cell
100%
Kinase
66%
Phosphotransferase
66%
Cell Cycle
33%
Cell Proliferation
33%
Tumor Progression
33%
Colony Formation
33%
S Phase
33%
Inhibitor of Apoptosis
33%
Proto Oncogene
33%
Pharmacodynamics
33%
Moloney Murine Leukemia Virus
33%
Cytochrome P450
33%
Serine
33%
Threonine
33%
Pharmacology, Toxicology and Pharmaceutical Science
Transitional Cell Carcinoma
100%
Bladder Cancer
40%
Biological Marker
20%
Malignant Neoplasm
20%
Neoplasm
20%
Multiple Myeloma
20%
Tumor Growth
20%
Phosphotransferase
20%
Disease Exacerbation
20%
Pharmacodynamics
20%
Bioavailability
20%
Cytochrome P450
20%
Leukemia
20%
Molecular Target
20%
Aciclovir
20%
Phosphotransferase Inhibitor
20%
Head and Neck Cancer
20%
Multiple Cancer
20%
Protein Serine Threonine Kinase
20%